George Freeman Departure Leaves UK Life Sciences Holding Its Breath
Executive Summary
Theresa May has re-structured the UK Department of Health ministerial team as part of her wide-ranging reshuffle and in so doing moved life sciences minister George Freeman over to chair the prime minister’s policy board. The British biopharma community says it hopes he will be replaced – and soon.
You may also be interested in...
UK's Life Science Minister Wants To Help NICE Say Yes To Innovation
George Freeman MP is the UK's first Minister for Life Sciences. In this exclusive interview with Scrip he highlights the UK government's priorities for boosting R&D in the UK.
Anjarium To Pioneer Next-Generation Non-Viral Gene Therapies
Emerging Company Profile: Switzerland-based Anjarium Biosciences AG has successfully raised $61m in a series A financing that will fund expansion of its novel proprietary platform and development of a nascent pipeline of non-viral gene therapies.
Incyte Plays Down Ruxolitinib Cream Label Worries Following Atopic Dermatitis Approval
Incyte welcomed FDA approval of its ruxolitinib cream, a selective JAK1/JAK2 inhibitor, as a treatment for atopic dermatitis, but criticized the boxed warnings label assigned to it.